MARIANNE AZNEER-HARBUT: Open Payments
NPI 1073653259 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 95 payments from 16 companies in 2025. Trend: 2023 $1,383 · 2024 $2,241 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $458 |
| Janssen Biotech, Inc. | 10 | $282 |
| PFIZER INC. | 11 | $165 |
| Novartis Pharmaceuticals Corporation | 16 | $150 |
| Galderma Laboratories, L.P. | 13 | $137 |
| Incyte Corporation | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| GENZYME CORPORATION | 2 | $71 |
| Lilly USA, LLC | 3 | $69 |
| UCB, Inc. | 2 | $53 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, CIBINQO, RINVOQ, COSENTYX, NEMLUVIO, OPZELURA.
Industry payments across MI — which companies pay providers there.
